中文名称[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE,N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM
中文同义词[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE,N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM;1,2,4]三唑并[1,5-A]嘧啶-4(7H)-乙酰胺,N-[2-氯-4-(三氟甲基)苯基]-2-(3,6-二氢-2H-吡喃-4-基)-5-乙基-6-[4-[(5-羟基-6-甲基-4-吡喃;N-(2-氯-4-(三氟甲基)苯基)-2-(2-(3,6-二氢-2H-吡喃-4-基)-5-乙基-6-(4-(5-羟基-6-甲基嘧啶-4-羰基)哌嗪-1-基)-7-氧代-[1,2,4]三唑并[1,5-A]嘧啶-4(7H)-基)乙酰胺;[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE,N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYR;WERNER综合征RECQ解旋酶-IN-1,10MMDMSO溶液;WERNER综合征RECQ解旋酶-IN-1
英文名称[1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide,N-[2-chloro-4-(trifluoromethyl)phenyl]-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl]-1-piperazinyl]-7-oxo-
英文同义词[1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide,N-[2-chloro-4-(trifluoromethyl)phenyl]-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl]-1-piperazinyl]-7-oxo-;WernersyndromeRecQhelicase-IN-1;N-(2-chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl)-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide;WernersyndromeRecQhelicase-IN-1,10mMinDMSO;N-(2-chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)azine-1-yl)-7-oxy-[1,2,4]triazolebenzo[1,5-a]pyrimidine-4(7H)-yl)acetamide;RHO761;WernersyndromeRecQhelicase-IN-1HRO761
CAS号2869954-34-5
分子式C31H31ClF3N9O5分子量702.08
密度1.58±0.1g/cm3(Predicted)溶解度DMSO:Slightlysoluble:0.1-1mg/ml酸度系数(pKa)5.87±0.45(Predicted)形态固体颜色白色至浅黄色
关键字： HRO761;2869954-34-5;
湖北昭亿生物科技有限公司是一家立足湖北、深耕生物医药领域的创新型企业。公司依托湖北在光电子信息、生物医药及新材料等新兴产业的集群优势，深耕化工、食品、农业及科研等多个领域，包括化妆品原料、食品添加剂、饲料添加剂、兽药、农药、香精香料、医药原料、化工原料等产品技术为核心的生产、研发，致力于为客户提供高质量的产品与方案。后续昭亿生物将继续扎根荆楚大地，以严谨的科学态度和务实的产业精神，为中国生物医药产业的自主创新贡献“昭亿力量”。